Jul 10, 2023 · Myelodysplastic syndrome (also called myelodysplasia or more recently, myelodysplastic neoplasm) refers to a group of cancers that keep your blood (hematopoietic) …

Jun 13, 2025 · Yes. Roughly 25–30 % of people diagnosed with myelodysplastic syndromes (MDS) will develop acute myeloid leukemia (AML), usually within three to five years. The risk …

Nov 21, 2024 · Your bone marrow creates blood cells. With myelodysplastic syndromes, you can no longer make enough healthy cells. Learn about who might get the rare condition and …

MDS can also develop into a more serious cancer. In about 1 in 3 people with MDS, the disease can progress to acute myeloid leukemia (AML), a fast-growing cancer of bone marrow cells.

Jun 29, 2018 · Myelodysplastic syndrome (MDS) is a type of blood cancer (leukemia) in which the bone marrow, the spongy tissue inside some bones of the body, produces blood cells that …

The myelodysplastic syndrome (MDS) is group of clonal hematopoietic stem cell disorders typified by peripheral cytopenia, dysplastic hematopoietic progenitors, a hypercellular or hypocellular …

Oct 4, 2024 · Patients with a myelodysplastic syndrome and a high number of blasts in their bone marrow have a high risk of acute leukemia. They may be treated with the same chemotherapy …

Myelodysplastic syndrome refers to a group of related disorders in which abnormal blood-forming cells develop in the bone marrow. At first, these cells interfere with the production of normal …

Myelodysplastic Syndromes (MDS): Often considered a precursor to leukemia, MDS involves ineffective blood cell production due to abnormalities in the bone marrow. Such classifications …

Patients with MDS are cared for by expert oncologists in our Adult Leukemia Program. Our clinical and research teams are recognized leaders in MDS care and research.